EMMI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 8.964
EU - Europa 5.957
AS - Asia 1.285
AF - Africa 9
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 16.226
Nazione #
US - Stati Uniti d'America 8.937
PL - Polonia 1.892
IE - Irlanda 1.190
IT - Italia 1.177
SE - Svezia 774
HK - Hong Kong 571
CN - Cina 314
RU - Federazione Russa 234
JO - Giordania 203
CH - Svizzera 180
GB - Regno Unito 127
DE - Germania 114
VN - Vietnam 68
AT - Austria 55
ES - Italia 54
FI - Finlandia 53
TR - Turchia 35
UA - Ucraina 32
FR - Francia 29
CA - Canada 26
IN - India 23
SG - Singapore 22
BE - Belgio 17
SA - Arabia Saudita 14
KR - Corea 12
DK - Danimarca 11
NL - Olanda 9
IL - Israele 7
IR - Iran 7
GR - Grecia 5
PE - Perù 5
BR - Brasile 3
JP - Giappone 3
PS - Palestinian Territory 3
SC - Seychelles 3
EU - Europa 2
ID - Indonesia 2
MA - Marocco 2
MU - Mauritius 2
NG - Nigeria 2
AU - Australia 1
CZ - Repubblica Ceca 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
RO - Romania 1
TW - Taiwan 1
Totale 16.226
Città #
Warsaw 1.889
Fairfield 1.509
Dublin 1.188
Chandler 850
Ashburn 788
Woodbridge 647
Seattle 575
Houston 529
Cambridge 509
Wilmington 420
Lawrence 403
Altamura 356
Hong Kong 340
Princeton 280
Florence 234
Moscow 220
Ann Arbor 213
Boston 212
Bern 175
Beijing 173
Buffalo 152
San Diego 116
New York 114
Medford 98
Shanghai 79
Boardman 73
Kent 63
Dong Ket 56
Vienna 55
Falls Church 53
Norwalk 50
Barcelona 44
Hillsboro 35
London 32
Rome 30
Redwood City 29
Milan 27
Castelliri 23
Toronto 23
Andover 20
Los Angeles 20
Washington 18
West Jordan 18
Brussels 17
Guangzhou 17
Singapore 16
Jacksonville 15
Phoenix 13
Pune 12
Bologna 11
Copenhagen 11
Kilburn 11
Lappeenranta 11
Seoul 11
Bari 10
Dearborn 10
Genoa 9
Napoli 9
Paris 9
Redmond 9
Arezzo 7
Campi Bisenzio 7
Laurel 7
Nanjing 7
New Bedfont 6
Old Bridge 6
Palermo 6
Perugia 6
Riyadh 6
Rolla 6
Siena 6
Cerignola 5
Hangzhou 5
Inverurie 5
Jinan 5
Khobar 5
Lima 5
Padova 5
Trumbull 5
Cagliari 4
Chicago 4
Empoli 4
Hounslow 4
Izmir 4
Mumbai 4
Naaldwijk 4
Prescot 4
Saint-Fons 4
Taiyuan 4
Tel Aviv 4
Timonium 4
Verona 4
Altidona 3
Atlanta 3
Bilbao 3
Cinisello Balsamo 3
Duncan 3
Hefei 3
Helsinki 3
Insch 3
Totale 13.125
Nome #
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 238
Behçet's syndrome patients exhibit specific microbiome signature. 229
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 228
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 208
SIRT1 activity is decreased in lesional psoriatic skin 207
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 205
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 201
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 193
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 170
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 161
A biochemical approach to detect oxidative stress in infertile women undergoing assisted reproductive technology procedures 150
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 137
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 129
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 126
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 126
Thrombosis in vasculitis: from pathogenesis to treatment 122
ANCA-associated vasculitis in childhood: Recent advances 122
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 120
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 113
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report 106
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 106
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 103
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 102
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 101
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 100
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 100
Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: A proof of concept study 99
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 98
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome 98
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 97
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 95
Intravenous immunoglobulin therapy: a snapshot for the internist. 94
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 93
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 93
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 92
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 91
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 90
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 90
Thrombosis in inflammatory bowel diseases: What's the link? 89
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 89
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 89
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 89
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 87
Redox status alterations during the competitive season in élite soccer players: focus on peripheral leukocyte-derived ROS 86
Pulmonary hemorrhage: not only vasculitis. 85
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 84
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 84
Pathogenesis of Behcet Syndrome 83
Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis. 83
A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy. 81
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 79
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 79
The "multifaceted" onset of vasculitis neuropathy 79
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 77
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 76
Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion 76
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 76
The risk stratification in atrial fibrillation 74
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 74
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 74
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy 74
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 74
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 74
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 73
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 73
Sharing data of clinical trials 72
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study 71
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. 71
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 71
Vascular Behçet's syndrome: an update 70
The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies 70
An immune-molecular hypothesis supporting infectious aetiopathogenesis of Kawasaki disease in children 69
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 69
Infliximab and Cogan's syndrome 68
Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol 68
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 68
Kimura’s disease: case report of an Italian young male and response to oral cyclosporine A in an 8 years follow-up 67
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy 67
A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility 67
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 67
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 65
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 65
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 65
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 64
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 64
Anakinra for resistant Behçet uveitis: why not? 63
Microparticles: Bridging the gap between autoimmunity and thrombosis 62
Pharmacological prevention of venous thromboembolism in orthopaedic surgery 62
Modulation of gut microbiota through nutritional interventions in Behçet’s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial 62
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 62
Helicobacter pylori management in primary care. 61
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 61
Prognostic Value of Degree and Types of Anaemia on Clinical Outcomes for Hospitalised Older Patients 61
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 61
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 60
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 59
Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series 59
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role 59
null 59
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 59
Totale 9.462
Categoria #
all - tutte 69.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019544 0 0 0 0 0 0 0 0 0 0 290 254
2019/20202.830 146 146 62 173 321 308 329 333 326 233 237 216
2020/20212.768 155 257 102 463 240 211 223 168 307 326 147 169
2021/20221.959 56 75 231 74 50 130 50 215 125 82 281 590
2022/20235.067 450 1.102 267 219 219 878 682 266 496 63 181 244
2023/20242.352 92 172 343 162 164 353 128 483 79 237 139 0
Totale 16.698